Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

HCGCheck methods and identity

Why different hCG medicines have different labeled uses

3 numbered sourcesSource years 2021–2025

Short chains of amino acids joined by peptide bonds can serve as hormone signals. Human chorionic gonadotropin, abbreviated hCG, is a larger glycoprotein with two amino-acid chains and attached sugars. It acts at a receptor that also recognizes luteinizing hormone. The U.S. prescribing information for two hCG products shows why the general name and a particular approved product convey different information. [1, 2]

Pregnyl is a preparation of chorionic gonadotropin obtained from human pregnancy urine. Its U.S. label lists ovulation induction in specified infertility circumstances, selected cases of male hypogonadotropic hypogonadism and certain cases of prepubertal undescended testes without an anatomical obstruction. Ovidrel contains recombinant choriogonadotropin alfa, meaning it is produced using cells engineered to make the hormone. Its label describes use for final follicular maturation and early luteinization in patients undergoing assisted reproduction, and for ovulation induction in defined patients. [1, 2]

The receptor explains the shared thread among some of these uses. In the ovary, the luteinizing-hormone signal plays a role in final egg maturation and ovulation. In the testes, activation of the receptor can stimulate androgen production by Leydig cells. An older structural study used cryo-electron microscopy to examine how hCG binds and activates the receptor. The molecular image describes a physical interaction. Its relevance to a particular condition or product is established separately by clinical and regulatory evidence. [1, 2, 3]

The labels also describe risks tied to the use being studied or approved. In ovarian stimulation, one of those risks is ovarian hyperstimulation syndrome, an excessive response to the hormonal stimulation. The label for Pregnyl states that evidence does not support hCG as a treatment for obesity. The two approved medicines have their own product descriptions, indications and warnings. The older structural work and the product labels are the sources for these specific questions, while newer clinical trials tend to compare defined fertility approaches rather than revisiting what the labels cover. [1, 2, 3]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop HCG

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.